Innate Pharma (IPHA) Stock Chart & Stock Price History $1.82 +0.00 (+0.05%) As of 07/3/2025 01:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Innate Pharma Stock Price Performance The Innate Pharma (IPHA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 8.49%, with a year-to-date return of -1.03%. In the past month, the stock has decreased 15.30%, reflecting recent market activity. As of the latest close, Innate Pharma traded at $1.82 with a market cap of $167.85 million and volume of 204 shares. Five years ago, the stock traded at $6.45, representing a 71.77% decrease over that period. At the time, it had a market cap of $0.00 and a volume of 17,112 shares. Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.33%1 Month Performance-15.30%3 Month Performance-0.49%Year-To-Date Performance-1.03%1 Year Performance-8.49%5 Year Performance-71.77% IPHA Stock Chart for Saturday, July, 5, 2025 IPHA Chart by TradingView Innate Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$1.82$1.82$1.81$1.81204 shs$167.86 million07/03/2025$1.82$1.82+0.05%$1.81$1.81204 shs$167.85 million07/02/2025$1.85$1.82-1.36%$1.90$1.825,448 shs$167.77 million07/01/2025$1.82$1.85+1.65%$1.85$1.775,454 shs$170.07 million06/30/2025$1.85$1.82-1.89%$1.85$1.7114,261 shs$167.31 million06/27/2025$1.91$1.85-3.14%$1.92$1.823,484 shs$170.53 million06/26/2025$1.82$1.91+5.23%$1.91$1.754,859 shs$176.06 million06/25/2025$1.78$1.82+2.02%$1.78$1.7217,867 shs$167.31 million06/24/2025$1.80$1.78-1.17%$1.80$1.7623,418 shs$163.98 million06/23/2025$1.80$1.80$1.88$1.7120,145 shs$165.92 million Get the Latest News and Ratings for IPHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$1.90$1.80-5.26%$1.85$1.809,046 shs$165.92 million06/19/2025$1.90$1.90$1.90$1.834,654 shs$175.13 million06/18/2025$1.87$1.90+1.60%$1.90$1.834,654 shs$175.14 million06/17/2025$1.86$1.87+0.54%$1.92$1.826,508 shs$172.37 million06/16/2025$1.90$1.86-1.85%$1.94$1.8452,584 shs$171.45 million06/13/2025$1.98$1.90-4.29%$1.98$1.8712,580 shs$174.67 million06/12/2025$1.98$1.98+0.20%$2.00$1.957,057 shs$182.51 million06/11/2025$1.98$1.98-0.20%$2.02$1.9410,649 shs$182.14 million06/10/2025$2.12$1.98-6.38%$2.04$1.968,448 shs$182.51 million06/09/2025$2.15$2.12-1.63%$2.15$2.074,131 shs$194.95 million06/06/2025$2.15$2.15$2.19$2.139,610 shs$198.18 million06/05/2025$2.14$2.15+0.47%$2.21$2.0213,662 shs$198.18 million06/04/2025$2.14$2.14$2.20$2.143,813 shs$197.26 million Related Companies PHAT Stock Price Chart ANAB Stock Price Chart IMTX Stock Price Chart TRVI Stock Price Chart NUVB Stock Price Chart DAWN Stock Price Chart GHRS Stock Price Chart STOK Stock Price Chart SANA Stock Price Chart MRVI Stock Price Chart Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IPHA) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
